Lobbying

Ron Group, LLC, D/B/A Blue SKY Specialty Pharmacy's latest lobbying report covers Q1 2026, at under $5,000. Its first report covers Q4 2024; the issues it reports most are Health Issues.

Ron Group, LLC, D/B/A Blue SKY Specialty Pharmacy

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2024
The first quarter a report named it

Lobbying by quarter

Ron Group, LLC, D/B/A Blue SKY Specialty Pharmacy lobbying by quarter
Ron Group, LLC, D/B/A Blue SKY Specialty Pharmacy lobbying by quarter
QuarterAmountReports
Q4 2024$40K1
Q1 2025$20K1
Q2 2025$01
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$60K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health Resources & Services Administration (HRSA)2 reports
  • HOUSE OF REPRESENTATIVES2 reports
  • SENATE2 reports
  • Treasury, Dept of2 reports

Firms it paid

Firm
Bradley Arant Boult Cummings$60K6 quarters

Former officials lobbying for it

Former position
JOHN LUCAS ADAIRPolicy Advisor to the Under Secretary of EducationQ1 2025
MARTHA ROBYFormer Member of U.S. House of RepresentativesQ1 2025

Lobbying reports

Filed by
04/20for Q1Bradley Arant Boult CummingsUnder $5,000
01/20for Q4 2025Bradley Arant Boult CummingsUnder $5,000
25/10/20for Q3 2025Bradley Arant Boult CummingsUnder $5,000
25/07/21for Q2 2025Bradley Arant Boult CummingsUnder $5,000
25/04/21for Q1 2025Bradley Arant Boult Cummings$20K
25/01/21for Q4 2024Bradley Arant Boult Cummings$40K
25/01/03for Q4 2024Bradley Arant Boult CummingsUnder $5,000